Premium
Hydroxychloroquine‐induced hyperpigmentation: a case report
Author(s) -
Melikoglu M. A.,
Melikoglu M.,
Gurbuz U.,
Budak B. S.,
Kacar C.
Publication year - 2008
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1111/j.1365-2710.2008.00955.x
Subject(s) - hydroxychloroquine , mucocutaneous zone , dermatology , medicine , hyperpigmentation , rheumatoid arthritis , adverse effect , surgery , pathology , covid-19 , pharmacology , disease , infectious disease (medical specialty)
Summary The antimalarials are one of the most commonly prescribed drugs in medical practice, for conditions such as rheumatoid arthritis as well as malaria. They are generally well‐tolerated and the possible side effects of synthetic antimalarials, though infrequent, are well known. Besides the familiar adverse reactions, a localized mucocutaneous bluish‐grey to black discolouration can sometimes be seen with antimalarial drugs. The aim of this report was to draw attention to the localized mucocutaneous bluish‐grey hyperpigmentation induced by hydroxychloroquine with a case presentation and a review of the literature.